Table 1.
RF results of top 5 most important biomarkers (mean decrease in accuracy).
| Myocardial TG | Epicardial fat | Pericardial fat | Liver fat |
|---|---|---|---|
| Clinical Data | |||
| LV early diastole | Visceral fat | Waist | Waist |
| Waist | Leptin | Visceral fat | Fasting insulin |
| Weight | Insulin 1 h | Leptin | HOMA-index |
| AFABP | AFABP | Fasting insulin | Visceral fat |
| BMI | Fasting insulin | HOMA-index | Weight |
| Inflammation-Associated Proteome | |||
| FGF 21 | TNFSF 14 | HGF | CDCP1 |
| LAPTGF-β1 | FGF 21 | CDCP1 | FGF 21 |
| IL 18R1 | IL 18R1 | TNFSF 14 | HGF |
| HGF | HGF | TRAIL | IL 18R1 |
| CDCP1 | IL 6 | IL 18R1 | IL 6 |
| Lipidome | |||
| CE 20:3 | CE 20:3 | diSM 18:0 | TAG 50:1 |
| TAG 56:4 | PC 38:3 | LPC 18:2 | diSM 18:0 |
| PC 38:3 | LPC 16:1 | PC 38:3 | CE 20:3 |
| LPC 18:2 | TAG 52:1 | LPC 16:0 | SM 18:0 |
| CE 16:1 | CE 18:0 | CE 20:3 | TAG 52:1 |
| Metabolome | |||
| Glutamate | *PE (16:0/18:1) | *CER (d18:0/16:0) | Glutamate |
| Glucose | *PI (18:0/20:4) | Glutamate | γ- glutamyl-leucine |
| *DAG (16:0/18:2) | Glutamate | Glucose | *CER (d18:0/16:0) |
| *PE (18:0/20:4) | *PE (18:0/20:4) | *PC (18:0/20:4) | *DAG (16:0/18:2) |
| *PC (16:0/16:1) | *SM (d18:2/16:0, d18:1/16:1) | *SM (d18:2/16:0, d18:1/16:1) | *PE (16:0/18:1) |
*DAG (16:0/18:2) – 1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2); *PE (18:0/20:4) – 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4); *PC (16:0/16:1) – 1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1); *PE (16:0/18:1) – 1-palmitoyl-2-oleoyl-GPE (16:0/18:1); *PI (18:0/20:4) – 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4); ‘SM (d18:2/16:0, d18:1/16:1) – sphingomyelin (d18:2/16:0, d18:1/16:1); *CER (d18:0/16:0) – N-palmitoyl-sphinganine (d18:0/16:0); *PC (18:0/20:4) – 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4).